Global Renal Replacement Therapy Market Growth (Status and Outlook) 2023-2029

Global Renal Replacement Therapy Market Growth (Status and Outlook) 2023-2029

Renal replacement therapy (RRT) is therapy that replaces the normal blood-filtering function of the kidneys. It is used when the kidneys are not working well, which is called kidney failure and includes acute kidney injury and chronic kidney disease. Renal replacement therapy includes dialysis (hemodialysis or peritoneal dialysis), hemofiltration, and hemodiafiltration, which are various ways of filtration of blood with or without machines. Renal replacement therapy also includes kidney transplantation, which is the ultimate form of replacement in that the old kidney is replaced by a donor kidney.

LPI (LP Information)' newest research report, the “Renal Replacement Therapy Industry Forecast” looks at past sales and reviews total world Renal Replacement Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Renal Replacement Therapy sales for 2023 through 2029. With Renal Replacement Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Renal Replacement Therapy industry.

This Insight Report provides a comprehensive analysis of the global Renal Replacement Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Renal Replacement Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Renal Replacement Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Renal Replacement Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Renal Replacement Therapy.

The global Renal Replacement Therapy market size is projected to grow from US$ 92850 million in 2022 to US$ 128580 million in 2029; it is expected to grow at a CAGR of 4.8% from 2023 to 2029.

Fresenius is one of the most important global key players of the renal replacement therapy, holds about 20% of shares of the global renal replacement therapy market, other key players include DaVita, Baxter, etc. North America is the largest market, occupied for about 40 percent, followed by the Asia Pacific. In terms of type, services is the largest segment, with a share of over 80%, and in terms of end user, the dialysis center segment holds a share of over 60 percent.

This report presents a comprehensive overview, market shares, and growth opportunities of Renal Replacement Therapy market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Devices
Dialyzer
Other Consumables
Services

Segmentation by application
Hospital
Dialysis Center
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Fresenius
DaVita
Baxter
US rental care
B.Braun
Diaverum
Nipro
Asahi Kasei
Nikkiso
Toray
WEGO
JMS
Medtronic
SWS Hemodialysis Care
DIALIFE SA

Please note: The report will take approximately 2 business days to prepare and deliver.